Immune System News and Research

RSS

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

Researchers are unveiling new data on investigational findings in nearly 450 abstracts on the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Miami Beach, Fla., Nov. 5-10.

9 Nov 2009

Cellular mechanisms that may impact immune functions in the elderly discovered

Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

9 Nov 2009

Researchers develop tools to visualize how different cell populations of cells communicate

Using imaging mass spectrometry, researchers at the University of California, San Diego have developed tools that will enable scientists to visualize how different cell populations of cells communicate. Their study shows how bacteria talk to one another - an understanding that may lead to new therapeutic discoveries for diseases ranging from cancer to diabetes and allergies.

9 Nov 2009

Researchers find compound that reverses type 1 myotonic dystrophy

A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York.

7 Nov 2009

Rituximab drug potentially effective for treating Graves' eye disease, shows study

A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms - and improved vision - following treatment with the drug rituximab. Inflammation around their eyes and damage to the optic nerve were significantly reduced. The same patients had not previously responded to steroids, a common treatment for Graves' eye disease.

7 Nov 2009

Genetix Pharmaceuticals develops a gene therapy product to treat ALD

Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced today the company’s clinical program to treat Adrenoleukodystrophy (ALD). The company is developing a gene therapy product in collaboration with Professor Patrick Aubourg and Doctor Nathalie Cartier of the National Institute of Health and Medical Research (INSERM).

7 Nov 2009

GeoVax Labs announces financial results and operational update for the third quarter of 2009

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.

6 Nov 2009

National Institutes of Health grants $6-million for brain disease research

Brown University, in collaboration with two other institutions, has been awarded a five-year, $6-million National Institutes of Health program project grant to help determine how a virus that can cause a rare brain disease attaches to host cells.

6 Nov 2009

CREW urge HHS to investigate CDC's approval to distribute H1NI vaccine to Wall Street firms

Today, Citizens for Responsibility and Ethics in Washington (CREW) asked Health and Human Service (HHS) Secretary Kathleen Sebelius to investigate why the Center for Disease Control (CDC) approved the distribution of the H1NI vaccine to Wall Street firms at a time when the vaccine is unavailable to most Americans.

6 Nov 2009

NABT to recognize Leonard C. Yannielli with the 2009 Evolution Education Award

The National Association of Biology Teachers (NABT) will recognize Leonard C. Yannielli, professor of biological sciences at Naugatuck Valley Community College (NVCC) in Waterbury, Connecticut, with the 2009 Evolution Education Award during the NABT annual professional development conference to be held 11-14 November 2009 in Denver, Colorado.

6 Nov 2009

Endothelin increases T cells in the kidneys leading to renal injury

A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both.

6 Nov 2009

New findings may lead to novel therapeutic approaches for HIV and prostate cancer

New Haven, Conn.-Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.

6 Nov 2009

Alliance Québécoise du Psoriasis provides information concerning H1N1 vaccination campaign

The Alliance Québécoise du Psoriasis (Quebec psoriasis alliance) would like to give its members and other psoriasis sufferers information concerning the massive H1N1 vaccination campaign.

6 Nov 2009

Climate change is the biggest health threat to children in the 21st century, says new report

Climate change is the biggest health threat to children in the 21st century and represents an immediate global emergency, according to a new report, "Feeling the Heat," released today by Save the Children, at the Barcelona United Nations Climate Change talks.

6 Nov 2009

ImmunoLin provides immediate benefit to the function of immune system and gut

A new study provides evidence that ImmunoLin®, an all natural and GRAS approved source of immunoglobulin, will provide immediate benefit to the function of the immune system and the gut. Immunoglobulins, or antibodies, are specialized proteins found in blood that the immune system naturally produces for immunity.

6 Nov 2009

Scientists identify new behavioral traits of immune cells; findings may help in understanding complex diseases

In diseases such as multiple sclerosis, cells of the immune system infiltrate the brain tissue, where they cause immense damage. For many years, it was an enigma as to how these cells can escape from the bloodstream. This is no trivial feat, given that specialized blood vessels act as a barrier between the nervous system and the bloodstream.

6 Nov 2009

Rice University's new BRC awarded $2M NIH grant to develop an inexpensive test for oral cancer

The National Institutes of Health (NIH) has awarded researchers in Rice University's new BioScience Research Collaborative (BRC) a $2 million Grand Opportunity (GO) grant to develop a fast, inexpensive test for oral cancer that a dentist could perform simply by using a brush to collect a small sample of cells from a patient's mouth.

6 Nov 2009

New biosensor device may help in combating cancer

A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.

5 Nov 2009

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new data related to its overall delivery research efforts including the rational design of Mimetic Lipoprotein Particles, or MLPs, a novel technology for the systemic delivery of small interfering RNAs, or siRNAs, the molecules that mediate RNAi.

5 Nov 2009

Prenatal DHA, a product developed for pregnant women to ensure adequate DHA, introduced

Nordic Naturals Professional Exclusive Division announces Prenatal DHA, a product developed especially for pregnant women to ensure adequate DHA, an important omega-3 essential fatty acid and a vital nutrient for the new mother and developing baby.

5 Nov 2009

Immune System News and Research

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

Cellular mechanisms that may impact immune functions in the elderly discovered

Researchers develop tools to visualize how different cell populations of cells communicate

Researchers find compound that reverses type 1 myotonic dystrophy

Rituximab drug potentially effective for treating Graves' eye disease, shows study

Genetix Pharmaceuticals develops a gene therapy product to treat ALD

GeoVax Labs announces financial results and operational update for the third quarter of 2009

National Institutes of Health grants $6-million for brain disease research

CREW urge HHS to investigate CDC's approval to distribute H1NI vaccine to Wall Street firms

NABT to recognize Leonard C. Yannielli with the 2009 Evolution Education Award

Endothelin increases T cells in the kidneys leading to renal injury

New findings may lead to novel therapeutic approaches for HIV and prostate cancer

Alliance Québécoise du Psoriasis provides information concerning H1N1 vaccination campaign

Climate change is the biggest health threat to children in the 21st century, says new report

ImmunoLin provides immediate benefit to the function of immune system and gut

Scientists identify new behavioral traits of immune cells; findings may help in understanding complex diseases

Rice University's new BRC awarded $2M NIH grant to develop an inexpensive test for oral cancer

New biosensor device may help in combating cancer

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Prenatal DHA, a product developed for pregnant women to ensure adequate DHA, introduced

Immunology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News